AMZN
Amazon.com, Inc.
AMZN has the edge over ESCA overall, supported by stronger modeled upside and stronger valuation.
ESCA
Escalade, Incorporated
ESCA offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
ESCA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Strong |
ESCA's profitability, cash flow and balance sheet are currently strong, and its revenue is stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over ESCA in the historical PE scenario, which offers more potential upside but is not a forecast.
ESCA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.9x | $15.66 | -25% |
| Current | 12x | $20.99 | — |
| Fair | 14x | $24.67 | +18% |
| Expensive | 18x | $30.70 | +46% |
Historical ranges are pointers, not guarantees.
ESCA's PE is in its fair range at 12x.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
ESCA Forward outlook
There aren't enough analyst estimates for ESCA to show an outlook.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over ESCA on earnings, with more consistent year-over-year improvement.
ESCA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $1.75 | +90% |
| Q2 2026 | $1.67 | +82% |
| Q1 2026 | $1.12 | +13% |
| Q4 2025 | $0.99 | +6.5% |
| Q3 2025 | $0.92 | -2.1% |
| Q2 2025 | $0.92 | +8.2% |
| Q1 2025 | $0.99 | +8.8% |
| Q4 2024 | $0.93 | +31% |
ESCA earned $1.75 per share over the past year, up 90% from the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over ESCA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over ESCA on profitability, with a higher operating margin.
ESCA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $65.6M | -3.2% |
| Q2 2026 | $57.7M | +6.2% |
| Q1 2026 | $55.8M | +0.6% |
| Q4 2025 | $62.6M | -2.2% |
| Q3 2025 | $67.8M | +0.1% |
| Q2 2025 | $54.3M | -13% |
| Q1 2025 | $55.5M | -3.2% |
| Q4 2024 | $63.9M | -2.4% |
ESCA's revenue fell from its 2021 peak and has held roughly level since: $66M last quarter, down 3.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 13% | +2.4 points |
| Q2 2026 | 21% | +16 points |
| Q1 2026 | 10% | +3.9 points |
| Q4 2025 | 8.2% | +1.2 points |
| Q3 2025 | 11% | -1 points |
| Q2 2025 | 4.8% | -2.3 points |
| Q1 2025 | 6.6% | +1.2 points |
| Q4 2024 | 7.1% | -0.5 points |
ESCA's operating margin was 13% last quarter, up 2.4 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
ESCA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $14M | +$15.2M |
| Q2 2026 | $8.2M | -36% |
| Q1 2026 | $5.3M | +63% |
| Q4 2025 | $13.7M | +16% |
| Q3 2025 | -$1.3M | -112% |
| Q2 2025 | $12.9M | +3.1% |
| Q1 2025 | $3.2M | +$3.6M |
| Q4 2024 | $11.7M | -42% |
ESCA has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
ESCA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1K shares |
| 1 year | +0.2% | +31K shares |
| 3 years | +0.1% | +15K shares |
| 5 years | +0.7% | +94K shares |
| Available history | -3.7% | -537K shares |
ESCA has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $1M |
| Q1 2026 | $281,000 |
| Q4 2025 | $927,000 |
| Q3 2025 | — |
| Q2 2025 | $790,000 |
| Q1 2025 | $1.4M |
| Q4 2021 | $1.3M |
ESCA spent $2M buying back its own shares over the past year.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
ESCA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | 0.3x | Very low |
| Q3 2025 | 0.7x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 0.8x | Very low |
ESCA has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
ESCA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.3 | Neutral |
| Stochastic | 49.4 | Neutral |
ESCA's weekly RSI is 60 (neutral) and its Stochastic is 49 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
ESCA PE vs Consumer Cyclical Sector
| Metric | ESCA | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 18x | 33% below |
| PE % | 36 | 47 | 11 pts below |
ESCA has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
ESCA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $19.5 | 7.8% above |
| 20 week MA | $19.7 | 6.4% above |
| 50 week MA | $17.6 | 19% above |
| 100 week MA | $15.7 | 33% above |
| 200 week MA | $15.3 | 38% above |
ESCA is in an uptrend: it's above all five of its weekly moving averages, and 38% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
ESCA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.79 | $21.7 | +122% |
| 2021 | $21.7 | $15.7 | -28% |
| 2022 | $15.7 | $9.81 | -37% |
| 2023 | $9.81 | $20.1 | +105% |
| 2024 | $20.1 | $14.4 | -29% |
| 2025 | $14.4 | $13.4 | -6.8% |
| 2026 YTD | $13.4 | $21.0 | +57% |
ESCA has the edge over AMZN on returns for 2026, with the stronger performance.